Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Clarivate
CLVT
$1.32B
| $5.28M | ﹤0.01% |
191,973
+165,734
| +632% | +$4.56M |
|
1827
Ryder
R
$9.8B
| $5.28M | ﹤0.01% |
71,098
+20,649
| +41% | +$1.63M |
|
|
GRFS
1828
Grifois
GRFS
$5.58B
| $5.28M | ﹤0.01% |
304,371
+17,360
| +6% | +$311K |
|
1829
Bankunited
BKU
$3.36B
| $5.27M | ﹤0.01% |
123,405
+39,338
| +47% | +$1.8M |
|
1830
CALL
Prologis
PLD
$136B
| $5.26M | ﹤0.01% |
44,000
| – | – |
|
1831
Ultragenyx Pharmaceutical
RARE
$2.49B
| $5.26M | ﹤0.01% |
55,165
+7,137
| +15% | +$744K |
|
1832
First Trust Rising Dividend Achievers ETF
RDVY
$24.5B
| $5.25M | ﹤0.01% |
109,382
+68,963
| +171% | +$3.3M |
|
1833
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $5.24M | ﹤0.01% |
55,065
-946
| -2% | -$89K |
|
1834
Gevo
GEVO
$348M
| $5.22M | ﹤0.01% |
717,418
+332,813
| +87% | +$2.43M |
|
1835
Kodiak Sciences
KOD
$2.44B
| $5.22M | ﹤0.01% |
56,086
+13,944
| +33% | +$1.34M |
|
1836
Opendoor
OPEN
$3.71B
| $5.21M | ﹤0.01% |
303,396
+254,154
| +516% | +$4.37M |
|
1837
CALL
Medtronic
MDT
$113B
| $5.2M | ﹤0.01% |
41,900
+1,800
| +4% | +$226K |
|
|
MANT
1838
DELISTED
Mantech International Corp
MANT
| $5.19M | ﹤0.01% |
59,945
+13,721
| +30% | +$1.19M |
|
1839
Sunstone Hotel Investors
SHO
$2.2B
| $5.17M | ﹤0.01% |
416,634
-64,702
| -13% | -$824K |
|
1840
CALL
Cleveland-Cliffs
CLF
$6.4B
| $5.17M | ﹤0.01% |
240,000
+90,000
| +60% | +$1.77M |
|
1841
Allogene Therapeutics
ALLO
$611M
| $5.17M | ﹤0.01% |
198,288
+74,327
| +60% | +$2.12M |
|
1842
Restaurant Brands International
QSR
$26.1B
| $5.17M | ﹤0.01% |
80,160
+18,106
| +29% | +$1.22M |
|
1843
Agios Pharmaceuticals
AGIO
$2.08B
| $5.17M | ﹤0.01% |
93,807
-14,319
| -13% | -$801K |
|
|
DEN
1844
DELISTED
Denbury Inc.
DEN
| $5.15M | ﹤0.01% |
67,114
+21,505
| +47% | +$1.31M |
|
1845
CALL
PNC Financial Services
PNC
$99.4B
| $5.15M | ﹤0.01% |
+27,000
| New | +$5.07M |
|
1846
Varonis Systems
VRNS
$4.81B
| $5.15M | ﹤0.01% |
89,402
+11,826
| +15% | +$616K |
|
1847
Vericel Corp
VCEL
$2.34B
| $5.14M | ﹤0.01% |
97,890
-5,755
| -6% | -$328K |
|
|
TGI
1848
DELISTED
Triumph Group
TGI
| $5.14M | ﹤0.01% |
247,596
-3,837
| -2% | -$70.7K |
|
1849
Essential Utilities
WTRG
$11.5B
| $5.14M | ﹤0.01% |
112,429
-13,708
| -11% | -$643K |
|
|
CIM
1850
Chimera Investment
CIM
$1.06B
| $5.13M | ﹤0.01% |
113,509
+85,382
| +304% | +$3.55M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.